The following tables summarize the impacts of ASC 842 on the Company’s condensed consolidated financial statements:

	For the Quarter Ended June 30, 2019
	As Reported			Adjustments			Balances Without Adoption of ASC 842
Net sales	$	134,285		$	—		$	134,285
Cost of sales		87,349			—			87,349
Gross profit		46,936			—			46,936
Selling, general and administrative expenses		36,809			(34	)		36,775
(Gain) loss on disposal of fixed assets		(55	)		—			(55	)
Operating income		10,182			34			10,216
Interest expense, net		1,017			—			1,017
Income from continuing operations before income taxes		9,165			34			9,199
Income tax expense		2,559			9			2,568
Income from continuing operations	$	6,606		$	25		$	6,631

	For the Six Months Ended June 30, 2019
	As Reported			Adjustments			Balances Without Adoption of ASC 842
Net sales	$	273,400		$	—		$	273,400
Cost of sales		180,905			—			180,905
Gross profit		92,495			—			92,495
Selling, general and administrative expenses		71,277			(67	)		71,210
(Gain) loss on disposal of fixed assets		(98	)		—			(98	)
Impairment charges		916			—			916
Operating income		20,400			67			20,467
Interest expense, net		2,066			—			2,066
Income from continuing operations before income taxes		18,334			67			18,401
Income tax expense		5,085			18			5,103
Income from continuing operations	$	13,249		$	49		$	13,298

	As of June 30, 2019
	As Reported			Adjustments			Balances Without Adoption of ASC 842
Assets
Right of use asset - operating leases	$	5,983		$	(5,983	)	$	—
Deferred tax asset		6,490			316			6,806

Liabilities
Other current liabilities	$	14,639		$	242		$	14,881
Operating lease liability - short-term		2,000			(2,000	)		—
Operating lease liability - long-term		4,225			(4,225	)		—
Other liabilities		22,813			1,169			23,982

Shareholders’ Equity
Retained deficit	$	(136,557	)	$	(853	)	$	(137,410	)